메뉴 건너뛰기




Volumn 5, Issue 5, 2010, Pages 601-605

Pharmacokinetics of erlotinib and its active metabolite OSI-420 in patients with non-small cell lung cancer and chronic renal failure who are undergoing hemodialysis

Author keywords

Erlotinib; Hemodialysis; Non small cell lung cancer

Indexed keywords

DRUG METABOLITE; ERLOTINIB; OSI 420; UNCLASSIFIED DRUG;

EID: 77951878714     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181d32287     Document Type: Article
Times cited : (52)

References (17)
  • 1
    • 0033542845 scopus 로고    scopus 로고
    • Cancer in patients on dialysis for end-stage renal disease: An international collaborative study
    • Maisonneuve P, Agodoa L, Gellert R, et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999;354:93-99.
    • (1999) Lancet , vol.354 , pp. 93-99
    • Maisonneuve, P.1    Agodoa, L.2    Gellert, R.3
  • 2
    • 17844372539 scopus 로고    scopus 로고
    • Critical update and emerging trends in epidermal growth factor receptor targeting in cancer
    • Baselga J, Arteaga CL. Critical update and emerging trends in epidermal growth factor receptor targeting in cancer. J Clin Oncol 2005;23:2445-2459.
    • (2005) J Clin Oncol , vol.23 , pp. 2445-2459
    • Baselga, J.1    Arteaga, C.L.2
  • 3
    • 22044445517 scopus 로고    scopus 로고
    • Erlotinib in previously treated non-small-cell lung cancer
    • Shepherd FA, Rodrigues Pereira J, Ciuleanu T, et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005;353: 123-132.
    • (2005) N Engl J Med , vol.353 , pp. 123-132
    • Shepherd, F.A.1    Rodrigues Pereira, J.2    Ciuleanu, T.3
  • 4
    • 33947504732 scopus 로고    scopus 로고
    • Phase II clinical trial of chemotherapy-naive patients- or- 70 years of age treated with erlotinib for advanced non-small-cell lung cancer
    • Jackman DM, Yeap BY, Lindeman NI, et al. Phase II clinical trial of chemotherapy-naive patients- or- 70 years of age treated with erlotinib for advanced non-small-cell lung cancer. J Clin Oncol 2007; 25:760-766.
    • (2007) J Clin Oncol , vol.25 , pp. 760-766
    • Jackman, D.M.1    Yeap, B.Y.2    Lindeman, N.I.3
  • 5
    • 58149132477 scopus 로고    scopus 로고
    • Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2
    • Hesketh PJ, Chansky K, Wozniak AJ, et al. Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2. J Thorac Oncol 2008;3:1026-1031.
    • (2008) J Thorac Oncol , vol.3 , pp. 1026-1031
    • Hesketh, P.J.1    Chansky, K.2    Wozniak, A.J.3
  • 6
    • 39749087795 scopus 로고    scopus 로고
    • Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non-smallcell lung cancer and a performance status of 2
    • Lilenbaum R, Axelrod R, Thomas S, et al. Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non-smallcell lung cancer and a performance status of 2. J Clin Oncol 2008;26: 863-869.
    • (2008) J Clin Oncol , vol.26 , pp. 863-869
    • Lilenbaum, R.1    Axelrod, R.2    Thomas, S.3
  • 7
    • 44249121733 scopus 로고    scopus 로고
    • Erlotinib for advanced non-small-cell lung cancer in the elderly: An analysis of the National Cancer Institute of Canada clinical trials group study BR. 21
    • Wheatley-Price P, Ding K, Seymour L, et al. Erlotinib for advanced non-small-cell lung cancer in the elderly: an analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR. 21. J Clin Oncol 2008;26:2350-2357.
    • (2008) J Clin Oncol , vol.26 , pp. 2350-2357
    • Wheatley-Price, P.1    Ding, K.2    Seymour, L.3
  • 8
    • 34249733299 scopus 로고    scopus 로고
    • Safety profile of erlotinib in patients with advanced non-small cell lung cancer with chronic renal failure
    • Gridelli C, Maione P, Galetta D, et al. Safety profile of erlotinib in patients with advanced non-small cell lung cancer with chronic renal failure. J Thorac Oncol 2007;2:96-98.
    • (2007) J Thorac Oncol , vol.2 , pp. 96-98
    • Gridelli, C.1    Maione, P.2    Galetta, D.3
  • 9
    • 34547701893 scopus 로고    scopus 로고
    • Phase i and pharmacokinetic study of erlotinib for solid tumors in patients with hepatic or renal dysfunction: CALGB 60101
    • Miller AA, Murry DJ, Owzar K, et al. Phase I and pharmacokinetic study of erlotinib for solid tumors in patients with hepatic or renal dysfunction: CALGB 60101. J Clin Oncol 2007;25:3055-3060.
    • (2007) J Clin Oncol , vol.25 , pp. 3055-3060
    • Miller, A.A.1    Murry, D.J.2    Owzar, K.3
  • 10
    • 10944226719 scopus 로고    scopus 로고
    • Simultaneous determination of OSI-774 and its major metabolite OSI-420 in human plasma by using HPLC with UV detection
    • Zhang W, Siu LL, Moore MJ, et al. Simultaneous determination of OSI-774 and its major metabolite OSI-420 in human plasma by using HPLC with UV detection. J Chromatogr B Analyt Technol Biomed Life Sci 2005;814:143-147.
    • (2005) J Chromatogr B Analyt Technol Biomed Life Sci , vol.814 , pp. 143-147
    • Zhang, W.1    Siu, L.L.2    Moore, M.J.3
  • 11
    • 37249041552 scopus 로고    scopus 로고
    • Phase i dose-finding and pharmacokinetic study of the oral epidermal growth factor receptor tyrosine kinase inhibitor Ro50-8231 (erlotinib) in Japanese patients with solid tumors
    • Yamamoto N, Horiike A, Fujisaka Y, et al. Phase I dose-finding and pharmacokinetic study of the oral epidermal growth factor receptor tyrosine kinase inhibitor Ro50-8231 (erlotinib) in Japanese patients with solid tumors. Cancer Chemother Pharmacol 2008;61:489-496.
    • (2008) Cancer Chemother Pharmacol , vol.61 , pp. 489-496
    • Yamamoto, N.1    Horiike, A.2    Fujisaka, Y.3
  • 12
    • 0038343126 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics: Maximizing the clinical potential of Erlotinib (Tarceva)
    • Hidalgo M, Bloedow D. Pharmacokinetics and pharmacodynamics: maximizing the clinical potential of Erlotinib (Tarceva). Semin Oncol 2003;30(3 suppl 7):25-33.
    • (2003) Semin Oncol , vol.30 , Issue.3 SUPPL. 7 , pp. 25-33
    • Hidalgo, M.1    Bloedow, D.2
  • 13
    • 0030774045 scopus 로고    scopus 로고
    • Induction of apoptosis and cell cycle arrest by CP-358, 774, an inhibitor of epidermal growth factor receptor tyrosine kinase
    • Moyer JD, Barbacci EG, Iwata KK, et al. Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase. Cancer Res 1997;57:4838-4848.
    • (1997) Cancer Res , vol.57 , pp. 4838-4848
    • Moyer, J.D.1    Barbacci, E.G.2    Iwata, K.K.3
  • 14
    • 0032695910 scopus 로고    scopus 로고
    • Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinomas with CP-358, 774: Dynamics of receptor inhibition in situ and antitumor effects in athymic mice
    • Pollack VA, Savage DM, Baker DA, et al. Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinomas with CP-358,774: dynamics of receptor inhibition in situ and antitumor effects in athymic mice. J Pharmacol Exp Ther 1999;291: 739-748.
    • (1999) J Pharmacol Exp Ther , vol.291 , pp. 739-748
    • Pollack, V.A.1    Savage, D.M.2    Baker, D.A.3
  • 15
    • 33646238486 scopus 로고    scopus 로고
    • Effects of smoking on the pharmacokinetics of erlotinib
    • Hamilton M, Wolf JL, Rusk J, et al. Effects of smoking on the pharmacokinetics of erlotinib. Clin Cancer Res 2006;12(7 Pt 1):2166-2171.
    • (2006) Clin Cancer Res , vol.12 , Issue.7 PART 1 , pp. 2166-2171
    • Hamilton, M.1    Wolf, J.L.2    Rusk, J.3
  • 16
    • 58149181583 scopus 로고    scopus 로고
    • Overview of regular dialysis treatment in Japan as of 31 Decembe 2006
    • Nakai S, Masakane I, Akiba T, et al. Overview of regular dialysis treatment in Japan as of 31 December 2006. Ther Apher Dial 2008;12: 428-456.
    • (2008) Ther Apher Dial , vol.12 , pp. 428-456
    • Nakai, S.1    Masakane, I.2    Akiba, T.3
  • 17
    • 34948911363 scopus 로고    scopus 로고
    • End-stage renal disease in the United States: An update from the United States Renal Data System
    • Foley RN, Collins AJ. End-stage renal disease in the United States: an update from the United States Renal Data System. J Am Soc Nephrol 2007;18:2644-2648.
    • (2007) J Am Soc Nephrol , vol.18 , pp. 2644-2648
    • Foley, R.N.1    Collins, A.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.